Who is the manufacturer of Expression MR400 MRI Patient Monitoring System?

Invivo Corporation filed the 510(k) submission for Expression MR400 MRI Patient Monitoring System (K152330).

What is the FDA product code for Expression MR400 MRI Patient Monitoring System?

MWI. It is classified under 21 CFR 870.2300 as a Class 2 device in the Cardiovascular panel.

What is the regulatory pathway for Expression MR400 MRI Patient Monitoring System?

510(k) clearance (submission type: Special).

What are the predicate devices for Expression MR400 MRI Patient Monitoring System?

MRI Patient Monitoring System (Model 865214) (K124061).

Who can help prepare an FDA 510(k) submission like Expression MR400 MRI Patient Monitoring System?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Expression MR400 MRI Patient Monitoring System

K152330 · Invivo Corporation · MWI · Dec 23, 2015 · Cardiovascular

Device Facts

Record ID	K152330
Device Name	Expression MR400 MRI Patient Monitoring System
Applicant	Invivo Corporation
Product Code	MWI · Cardiovascular
Decision Date	Dec 23, 2015
Decision	SESE
Submission Type	Special
Regulation	21 CFR 870.2300
Device Class	Class 2
Attributes	Pediatric

Intended Use

The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended to monitor vital signs for patients undergoing MRI procedures and to provide signals for synchronization for the MRI scanner. The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended for use by healthcare professionals. The Expression MR400 MRI Patient Monitoring System (Model MR400) provides monitoring for the following vital sign parameters: ECG, pulse oximetry (SpO2), non-invasive blood pressure (NIBP), and optionally, invasive blood pressure (IBP), carbon dioxide (CO2) and respiration rate, anesthetic agents, nitrous oxide (N2O), oxygen (02), and/or temperature.

Device Story

Multi-parameter patient monitoring system for MRI suites; monitors ECG, SpO2, NIBP, IBP, CO2, respiration, anesthetic agents, O2, N2O, and temperature. Inputs include physiological signals via wireless ECG/SpO2 modules and wired sensors (cuffs, probes, cannulas). System processes signals to display waveforms, numeric values, and alarms on a cart-mounted touchscreen. Provides synchronization signals for MRI scanners. Operated by healthcare professionals in MRI magnet rooms/suites. Output enables real-time patient status assessment and clinical decision-making during imaging. Benefits include continuous patient safety monitoring in high-field MRI environments.

Clinical Evidence

No clinical data was required. Substantial equivalence is supported by non-clinical verification, validation, and system-level performance testing, including hazard analysis and comparison against predicate specifications.

Technological Characteristics

Multi-parameter monitor with touchscreen cart. Wireless ECG/SpO2 modules (IP21 rated). Power: AC or internal battery. Parameters: ECG, SpO2, NIBP, IBP, CO2, anesthetic agents, O2, N2O, temperature. Connectivity: 10 user-selectable wireless networks. Software-based processing of physiological signals.

Indications for Use

Indicated for patients of all sizes (neonatal, infant, pediatric, adult, large adult) undergoing MRI procedures requiring vital sign monitoring and scanner synchronization. Intended for use by healthcare professionals.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

MRI Patient Monitoring System (Model 865214) (K124061)

Related Devices

K090785 — MRI COMPATIBLE PATIENT MONITORING SYSTEM, MODEL 865214 · Invivo Corp. · Dec 15, 2009
K172200 — 3880 MRI Patient Monitoring System · Iradimed Corporation · Oct 25, 2017
K062324 — MRI MONITOR WITH L-CANE05 AND L-CANE05A SOFTWARE AND MODULE OPTIONS N-PSNGV, N-PSNG, N-SNGV, N-SNG, N-PSN, N-SN · GE Healthcare · Dec 6, 2006
K050399 — MRI COMPATIBLE PATIENT MONITORING SYSTEM, MODEL 3160 · Invivo Research, Inc. · Aug 26, 2005
K142032 — MRI PATIENT MONITORING SYSTEM TESLA M3 · Mipm Mammendorfer Institut Fur Physik Und Medizin · May 7, 2015

Submission Summary (Full Text)

{0}------------------------------------------------ Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 December 23, 2015 Invivo Corporation c/o Christine Trefethen Regulatory Manager Philips Medical Systems 3000 Minuteman Rd. Andover, MA 01801 Re: K152330 Trade/Device Name: Expression MR400 MRI Patient Monitoring System (Model MR400) Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer and Rate Alarm) Regulatory Class: Class II Product Code: MWI Dated: November 24, 2015 Received: November 25, 2015 Dear Christine Trefethen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in {1}------------------------------------------------ the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Mitchell Stein for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K152330 Page 1 of 1 Device Name Expression MR400 MRI Patient Monitoring System (Model MR400) Indications for Use (Describe) The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended to monitor vital signs for patients undergoing MRI procedures and to provide signals for synchronization for the MRI scanner. The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended for use by healthcare professionals. The Expression MR400 MRI Patient Monitoring System (Model MR400) provides monitoring for the following vital sign parameters: ECG, pulse oximetry (SpO2), non-invasive blood pressure (NIBP), and optionally, invasive blood pressure (IBP), carbon dioxide (CO2) and respiration rate, anesthetic agents, nitrous oxide (N2O), oxygen (02), and/or temperature. Type of Use (Select one or both, as applicable) | <div> <input checked="true" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) </div> | <div> <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) </div> | |---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------| |---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------| #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the Invivo logo. The logo consists of a purple circle with the letter "i" inside, followed by the word "Invivo" in purple. Below the word "Invivo" is the text "A Philips Company" in gray. Image /page/3/Picture/1 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The background is white, which makes the blue letters stand out. ### SPECIAL 510(K) SUMMARY # SUBMITTER INFORMATION | Establishment Name: Establishment Address: | Invivo Corporation 12151 Research Parkway Orlando, FL 32826 USA | |-----------------------------------------------|------------------------------------------------------------------------------------------------| | Company Phone: | (407) 252-0414 | | Company Fax: | (407) 249-2022 | | Person to contact regarding questions: | Rusty Kelly Sr. Manager Quality and Regulatory (407)-252-0414 Rusty.Kelly@philips.com | | Establishment Registration Number: | 1051786 | ## DEVICE IDENTIFICATION Date Summary Prepared: | Trade name: | Expression MR400 MRI Patient Monitoring System (Model MR400) | |----------------------|-------------------------------------------------------------------------------------------------------| | Common name: | MRI patient monitoring system | | Classification name: | Cardiac monitor (including cardiotachometer and rate alarm) (21 CFR 870.2300, Product Code MWI) | August 11, 2015 {4}------------------------------------------------ #### IDENTIFICATION OF LEGALLY MARKETED PREDICATE DEVICE The Expression MR400 MRI Patient Monitoring System also referred to as the Expression MR400 or MR400, is substantially equivalent to the following predicate device: | Predicate Device | Manufacturer | 510(k) No. | Clearance Date | |-------------------------------------------------|--------------------|------------|----------------| | MRI Patient Monitoring System (Model 865214) | Invivo Corporation | K124061 | Feb 22, 2013 | #### DEVICE DESCRIPTION The Expression MR400 is a multi-parameter patient monitoring system used to monitor the vital signs of patients in an MRI magnet room and throughout an MRI suite. The MR400's software simultaneously processes and displays multiple parameters, waveforms, measurement numeric values and alarms. All patient information is provided on a wheeled cart which consists of a patient monitor with a touch screen display. The device is powered by either AC line power or its internal battery. The standard and optional parameters which can be monitored by the MR400 include: - Electrocardiogram (ECG) - Heart rate (HR, ECG and SPO2 derived) ● - Blood oxygen saturation/pulse oximetry (SPO2) - End-tidal and fractional inspired CO2 (EtCO2 and FiCO2) ● - Invasive blood pressure (IBP) (P1 and P2) ● - Anesthetic agents (AGENT) ● - o Desflurane (DES) - o Enflurane (ENF) - o Halothane (HAL) - o Isoflurane (ISO) - o Sevoflurane (SEV) - Fractional inspired O2 (FiO2), and end-tidal and fractional inspired N2O (EtN2O ● and FiN2O) - Temperature (TEMP) ● - Non-invasive blood pressure (NIBP) - . Respiration rate (CO2-derived and/or bellows-derived) {5}------------------------------------------------ The MR400 consists of the following key components: - Cart with touchscreen display ● - Wireless ECG module . - Wireless SpO2 module ● - Batteries for both the Cart and Wireless Modules ● - Battery charger ● - Power cord ● Accessories to the MR400 are offered to accommodate various patient sizes-neonatal, infant, pediatric, adult, and large adult. Key accessories include: - . ECG lead cables and electrodes - SPO2 probes and clips ● - NIBP cuffs and hoses ● - IBP transducer - Temperature probe and sheath ● - Cannulas ● - Water traps ● - Chest pneumograph ● - Expression IP5 (optional secondary display for control room w/printer) ● ### INDICATIONS FOR USE The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended to monitor vital signs for patients undergoing MRI procedures and to provide signals for synchronization for the MRI scanner. The Expression MR400 MRI Patient Monitoring System (Model MR400) is intended for use by healthcare professionals. The Expression MR400 MRI Patient Monitoring System (Model MR400) provides monitoring for the following vital sign parameters: ECG, pulse oximetry (SpO2), non-invasive blood pressure (NIBP), and optionally, invasive blood pressure (IBP), carbon dioxide (CO2) and respiration rate, anesthetic agents, nitrous oxide (N2O), oxygen (02), and/or temperature. #### TECHNOLOGICAL CHARACTERISTICS The modified device has the same fundamental scientific technology as the predicate device. {6}------------------------------------------------ | Technological Characteristic | Predicate: MRI Patient Monitoring System (K124061) | Modified Device: Expression MR400 MRI Patient Monitoring System | Comparison | |--------------------------------------------------------|--------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------| | Cart | | | | | Display | Detachable, located on top front of display | Permanently installed, located on the rear of the display | Substantially Equivalent | | Expression IP5 | Software is compatible with the predicate device | Software was updated to be compatible with the predicate device and the Expression MR400 | Substantially Equivalent | | Printer | Integrated on side of display | No printer permanently installed on display. | Substantially Equivalent | | Alarms Set Up, Printer Set Up and Monitor Set Up | Separate key on the keypad which is visible to the operator at all times | Collapsed within one Setup key on the virtual keypad that is visible to the operator at all times | Substantially Equivalent | | Power Supply | External | Integrated | Substantially Equivalent | | Internal Batteries | Four User-replaceable | Two Permanently installed and two User-replaceable | Substantially Equivalent | | Alarms | Vital Sign Alarms | Added user adjustable alarms for extreme bradycardia, extreme tachycardia, apnea and desaturation | Substantially Equivalent | | Non-Invasive Blood Pressure | | | | | NIBP Connector | Connector ports are for unique predicate accessories | Accommodate locking connectors unique to the modified device accessories | Substantially Equivalent | | NIBP Hose | 3 meters in length | 5 meters in length | Substantially Equivalent | | NIBP Data Collection & Measurement | Performed in the processing unit within the cart. | Performed in the processing unit within the cart using the picoNIBP OEM Module | Substantially Equivalent | | CO2 | | | | | CO2 Connector | Connector ports are for unique predicate accessories | Accommodate locking connectors unique to the modified device accessories | Substantially Equivalent | | CO2 Collection & Measurement CO2 cannula | Completed using Excelitas CO2 Sensor 22 ft. in length | Completed using LoFloC5 Co2 Sensor 17ft. in length | Substantially Equivalent | | ECG | | | | | ECG Cable Cover | Wire bundle enclosed in a silicone foam trunk | Flat wire assembly enclosed in Azote foam | Substantially Equivalent | | Wireless ECG Module- communication | 5 user-selectable networks | 10 user-selectable networks. (only 5 per module, either 1-5 or 6-10) | Substantially Equivalent | | Wireless ECG Module- battery | Operates on one (1) 3.7 VDC user-replaceable lithium battery | Operates on two (2) 3.7 VDC user-replaceable lithium batteries | Substantially Equivalent | | Wireless ECG Module- housing | Plastic covering, single battery slot, Ingress Protection IPX1 | Plastic housing made of same materials as predicate, supports two batteries, has eject buttons for batteries, improved Ingress Protection rating of IP21 | Substantially Equivalent | | SPO2 Wireless SPO2 Module- communication | 5 user-selectable networks | 10 user-selectable networks. (only 5 per module, either 1-5 or 6-10) | Substantially Equivalent | | Wireless SPO2 Module- housing | Plastic covering, single battery slot, Ingress Protection IPX1 | Plastic housing made of same materials as predicate, has eject button for battery, improved Ingress Protection rating of IP21 | Substantially Equivalent | {7}------------------------------------------------ #### SUMMARY OF NON-CLINICAL PERFORMANCE DATA Verification, validation, and testing activities establish the performance, functionality, and reliability characteristics of the modified device with respect to the predicate. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Pass/Fail criteria were based on the specifications cleared for the predicate device and the specifications of the modified device. Results of the non-clinical testing demonstrate that the modified device operates as intended within the performance specifications and is substantially equivalent to the cleared device. The results do not raise issues regarding the safety and effectiveness of the device. Clinical data was not required to substantiate claims of safety and effectiveness. The modified device, the Expression MR400 MRI Patient Monitoring System, described in this submission is substantially equivalent to the cleared device, the MRI Patient Monitoring System (Model 865214).